ライフサイエンスコーパス: decision to

1 that 3 variables significantly impacted the decision to ablate: (1) complication of radiofrequency a

2 ocal population obesity rates may affect the decision to accept obese individuals as donors.

3 3 m(2) as an intermediate range in which the decision to accept or decline is made on the basis of fa

4 Main outcome measures included participant's decision to accept or decline surgery, source of funding

5 ey is offered to a waitlisted candidate, the decision to accept or decline the organ relies primarily

6 A decision to accept was significantly more likely when be

7 l care bed availabilty and factors affecting decisions to accept patients to the intensive care unit.

8 s with relative risk reductions to influence decisions to accept therapy.

9 ional competition may influence a hospital's decision to acquire a surgical robot.

10 onkey to make it: some of them reflected the decision to act or refraining from acting (56%), whereas

11 which is necessary for contextually specific decisions to adapt to rapidly changing conditions.

12 Three strategies on which to base the decision to administer adjuvant chemotherapy were compar

13 VD patients (especially those with ACS), the decision to administer epinephrine for anaphylaxis can b

14 the order of 0.01 to 0.1, which supports the decision to administer prophylactic antibiotics.

15 The decision to administer radiotherapy should be made by th

16 uscitation were strongly associated with the decision to administer sodium bicarbonate (p<0.0001).

17 Decisions to administer opioids, sedatives, and antipsyc

18 to IPPV where the critical care team made a decision to admit (72/93 [77%] vs 21/93 [57%], p=0.018).

19 The decision to admit a patient to the ICU is complex, refle

20 itional research is needed to understand the decision to admit elderly patients to the ICU.

21 st that critical care bed availability and a decision to admit to critical care are associated with b

22 o admission was 2 h (IQR 1-3) with a bedside decision to admit, and 12 h otherwise (5-29).

23 uration should not be the only factor in the decision to admit, and its use may need to be reevaluate

24 tudinal factors that influence a household's decision to adopt and use new sanitation technologies.

25 The decision to adopt efficiency elements is often based on

26 outlays and continuing expenses can make the decision to adopt ReLACS foreboding.

27 Risk was not a consistent factor in decisions to adopt more controlling techniques.

28 ntify the factors associated with hospitals' decisions to adopt robotic technology and the consequenc

29 ry forward a level of confidence in previous decisions to affect subsequent decisions.

30 oth mechanisms were predictive of individual decisions to aggress, but observed patterns were better

31 U clinicians who were frequently involved in decisions to allocate ICU resources.

32 that modulate determinacy, specifically the decision to allow branch growth.

33 he gold standard evidence on which rests the decision to approve novel therapeutics for clinical use.

34 lateral prefrontal cortex at the time of the decision to assign an appropriate punishment through a d

35 nclude evidence-based interventions, support decisions to balance potential harms and benefits, and t

36 The median time from a final decision to be DNR until death was only 37 (7,70) days.

37 approach that considers individual movement decisions to be based explicitly on the sensory informat

38 ave not been completed, rendering management decisions to be based on extrapolation from adult data a

39 y to allow accurate assumptions and informed decisions to be made concerning the scope and clinical a

40 In doing so, we aim to clarify the decisions to be made for those who wish to develop and u

41 These differences permit lineage commitment decisions to be made in different hierarchical orders.

42 a particular position) to be highlighted and decisions to be made on which mutations may be acceptabl

43 entified factors that influence individuals' decisions to become organ donors, which may be effective

44 In budding yeast, the decision to begin a new cell cycle is regulated by three

45 igger medical consultations that result in a decision to begin ADHD treatment.

46 disease understanding and clinical treatment decisions to benefit patients.

47 y study outcomes were the initial triage and decision to biopsy concordance between in-person and tel

48 The Cohen kappa coefficients for decision to biopsy concordance were 0.35 and 0.61.

49 ate cancer, which could be used to guide the decision to biopsy.

50 ssay (PLA) for LINC00518/PRAME expression in decisions to biopsy a series of pigmented skin lesions.

51 attributable to changes in donor factors and decisions to biopsy and pump kidneys.

52 medications for IBD should not influence the decision to breast-feed and vice versa.

53 ed neural activation patterns discriminating decisions to buy cannabis from declined offers.

54 ehavioral choice support the notion that the decision to carry out one behavior rather than another d

55 therapeutic approaches, and make go or no-go decisions to carry new drug candidates forward into clin

56 We propose that decisions to cease and resume work are triggered by a co

57 how, when, and why individual ECs coordinate decisions to change shape, in relation to the myriad of

58 Uncertainty surrounds the decision to choose either treatment option.

59 m to: 1) validate the appropriateness of the decision to chronically anticoagulate; 2) guide clinicia

60 ient characteristics influenced the clinical decision to classify AF as paroxysmal or persistent.

61 nt differently, and their views affect their decisions to climb the corporate ladder (or not).

62 on Cancer AJCC Staging Manual 7th edition's decision to combine moderately and poorly differentiated

63 The decision to commit to spermatogenic differentiation coin

64 We first review evidence that decisions to communicate information are determined by t

65 human pharmacokinetic predictions led to the decision to conduct a human microdose study to determine

66 We aimed to define factors that influence decisions to consent for organ donation.

67 The decision to continue anticoagulation indefinitely after

68 -treatment (72 weeks) biopsies supported the decision to continue the trial (relative change in alani

69 oices, indicating growing uncertainty in the decision to continue.

70 ria parasite makes a fundamental and crucial decision: to continue to invade and proliferate or to di

71 We present an fMRI-based model predicting decisions to control emotion, finding that activity in b

72 roup members with high expertise varies from decision to decision.

73 and sociocultural factors contribute to the decision to decline care.

74 The interventions were not associated with decisions to decline newborn screening or withdraw resid

75 mably causes acute problems that lead to the decision to deliver.

76 d NICU managers should assess their staffing decisions to devote needed nursing care to critically il

77 We find that the decision to die is a germ cell-intrinsic process linked

78 Cells make decisions to differentiate, divide, or apoptose based on

79 atient values had no effect on intensivists' decisions to discuss withdrawal of life support with fam

80 Plasticity in the decision to disperse is taxonomically widespread and I p

81 The decision to disperse or remain philopatric between breed

82 een dispersal distance and plasticity in the decision to disperse.

83 ed anxieties about the consequences of their decision to donate.

84 se results cast doubt on the US EPA's recent decision to downscale its estimate of national natural g

85 During decisions to drink in general, greater activity was pres

86 In contrast, during decisions to drink that were demonstrably affected by th

87 the balance of values underlying the policy decision to eliminate nonmedical exemptions is clearly a

88 tralia, relatively little is known about the decisions to emigrate made by these nurses.

89 The decision to engage in food-seeking behavior depends not

90 Decisions to engage in collaborative interactions requir

91 The decision to enroll in a clinical trial is complex given

92 bspecialization in physician human resources decisions to ensure access to quality strabismus surgery

93 nt availability and stresses impact a cell's decision to enter a growth state or a quiescent state.

94 ate that neuropeptide signaling promotes the decision to enter dauer rather than reproductive develop

95 A decision to enter quiescence is suspected of occurring e

96 variability in pulse dynamics influences the decision to enter S phase.

97 ng pathway activation and contributes to the decision to enter the cell cycle is largely unknown.

98 However, the decision to establish and maintain a vaccine stockpile i

99 s known about individual determinants of the decision to establish paternity, in part because of data

100 ferent kind of more naturalistic decision--a decision to evaluate "what shall I do with it?" after th

101 mmes over the last decade has influenced the decision to evaluate treatment at earlier stages of the

102 encodes sensory and motor events related to decisions to execute, but not withhold, movements, imply

103 s underlying this variability is the agentic decision to exert control over emotional responses.

104 that DNA methylation is correlated with the decision to exit mitotic cell division and to enter cell

105 e, we designed a sequential task whereby the decision to exploit or forego an available offer was con

106 , we show that a stochastic, cell-autonomous decision to express ss is made intrinsically by each ss

107 fate is controlled by the binary stochastic decision to express the transcription factor Spineless i

108 the feeding motor hierarchy, to execute the decision to feed.

109 olar cells which must be integrated before a decision to fire is made.

110 Finally, we found that the decision to fire or not fire by individual DGCs was robu

111 RNAs), plays a key role in plants making the decision to flower by integrating into the known floweri

112 mortality, mortality after intervention, and decision to follow non-corrective treatment.

113 mortality over time, excluding patients with decision to forego life-sustaining therapy.

114 will describe the experiences that led to my decision to forge a career as an academic molecular anim

115 f a conservation landscape to show that this decision to "front-load" project spending can be subopti

116 Any decision to further expand the for-profit private hospit

117 ate expected incremental social value of the decision to grant access to a new treatment on the basis

118 s and high unmet needs and give guidance for decisions; to grant access for patients, to provide a do

119 in metastatic cancer cells that governs the decision to 'grow or go' (divide or invade).

120 and emotional aspects of CPM may affect the decision to have CPM and should be addressed when discus

121 extremely or very important factors in their decision to have CPM.

122 How patients make decisions to have surgery may contribute to this problem

123 y decreases in trustworthiness engendered by decisions to hide (experiments 3A and 3B).

124 known resistance amongEnterobacteriaceae The decision to implement these new breakpoints, including t

125 Our findings indicate that a regulatory decision to imprint or not is a functionally important m

126 ar monitoring are needed to inform treatment decisions to improve long-term cardiovascular health.

127 tify at-risk patients may refine therapeutic decisions to improve outcomes.

128 We made a pragmatic decision to include all studies to best reflect reality,

129 rmed to better enable tailoring of treatment decisions to individuals.

130 opram and the dopamine precursor levodopa on decisions to inflict pain on oneself and others for fina

131 of fate determinants impacts subsequent fate decisions to influence the numbers of DN4 cells arising

132 al approach to error disclosure in which the decision to inform the patient stems from within the org

133 s determined whether GM results impacted the decision to initiate antifungal therapy.

134 and the proportion of patients for whom the decision to initiate dialysis was based only on level of

135 The decision to initiate low-dose aspirin use for the primar

136 feration of nephron progenitor cells and the decision to initiate nephrogenesis are crucial events di

137 ccumbens (NAc) neurons naturally encodes the decision to initiate or suppress reward seeking when fac

138 In response, certain groups have opposed the decision to initiate pharmacologic treatment to lower bl

139 Whether CAC score can assist in guiding the decision to initiate statin treatment for primary preven

140 We modeled the larva's navigational decision to initiate turns as the output of a Linear-Non

141 ropriate in primary prevention when clinical decisions to initiate statin therapy are uncertain.

142 y disorders of the biliary system and thus a decision to inject Gd-EOB-DTPA was taken.

143 nd autoimmune disease and may facilitate the decision to institute anti-inflammatory treatment in the

144 f whom were discharged prior to 28-days post decision to intervene surgically.

145 There is great need to understand decisions to intervene restoratively and to find impleme

146 The decision to introduce IPV was based on preventing rare c

147 The decision to introduce or amend vaccination programmes is

148 The decision to introduce or delay chemotherapy must be bala

149 Continued surveillance is warranted as the decision to introduce protein conjugated vaccine in Indi

150 electively predict an opponent's yet unknown decision to invest in their common good or defect and di

151 s as the most important factor in making the decision to join a trial.

152 and self-motivated reasons behind patients' decisions to join a retinal trial.

153 with clinician pessimism and may affect the decision to limit care independent of a patient's severi

154 Involvement in the decision to limit life support allowed surrogates to reg

155 Participating in a decision to limit life support for a loved one in the IC

156 ling among bereaved surrogates involved in a decision to limit life support in the ICU.

157 ed the distress caused by participation in a decision to limit life support, the act of decision maki

158 Surrogate decision makers involved in decisions to limit life support for an incapacitated pat

159 Decisions to limit life-sustaining therapies are strongl

160 ently accurate to serve as the sole basis of decisions to limit treatment.

161 imics can regulate MAPKs, affecting cellular decisions to live or die.

162 w p21 regulates the proliferation-quiescence decision to maintain genomic stability.

163 scillatory activity that reflected subjects' decisions to make riskier choices.

164 eight, attractive features add little to the decision to mate.

165 nderlying model of the goods space, allowing decisions to meet current needs.

166 planatory power of self-assessed risk in the decision to migrate or stay and, equally important, conf

167 from similar studies, China-educated nurses' decisions to migrate are complex and not based solely on

168 ular circuitry may inform distinct cell fate decisions to Notch1 in epithelial tissues, where carcino

169 optimize procedural strategies including the decision to obtain epicardial access.

170 es a complex choreography of transcriptional decisions to obtain specific cellular identities.

171 mesothelium and allow appropriate cell fate decisions to occur in this multipotent mesoderm lineage.

172 primary care professionals individualize the decision to offer or refer adults without obesity who do

173 CT findings and physical examination on the decision to operate was analyzed.

174 r predictions across vignettes) and in their decisions to operate (49%-85%).

175 s explained 39% of the observed variation in decisions to operate across the four vignettes.

176 fits vary and are highly predictive of their decisions to operate.

177 eons' assessments of risk and in turn, their decisions to operate.

178 f this critical information guides physician decisions to optimize patient clinical outcomes.

179 arker of a patient's health, the physician's decision to order the test is based on multiple factors

180 An individual's decision to participate in a raid is strongly associated

181 ffered LCS and elected on the basis of their decision to pay (the out-of-pocket cost for LCS).

182 The decision to penalize hospitals for readmissions is compe

183 ting (56%), whereas others (44%) encoded the decision to perform (or withhold) a specific action (e.g

184 e the decision to proceed with CCTA, and the decision to perform a CAC scan should be balanced with t

185 ization status, this forms the basis for the decision to perform a DBPCFC, following a standardized d

186 of right subclavian vein contributed to the decision to perform recanalization by "body floss" techn

187 The decision to perform SLK rather than LTA is an important

188 -not arbitrary regulations-should inform the decision to prescribe opioids.

189 Decisions to prioritize reward consumption or pain avoid

190 The decision to probe early in the office or continue medica

191 ng the operation is "big surgery" and that a decision to proceed invoked a serious commitment for bot

192 t when the therapeutic window is narrow, the decision to proceed must be carefully balanced with a th

193 ess in trial outcome delivery, informing the decision to proceed or stop clinical evaluation of a tar

194 resolution of hematologic abnormalities, the decision to proceed to transplantation in these patients

195 Thus, CAC results should not influence the decision to proceed with CCTA, and the decision to perfo

196 The decision to proceed with reproductive development or und

197 Decisions to proceed with colectomy should be made based

198 Decisions to proceed with colon resection should be base

199 Decisions to proceed with surgical versus percutaneous r

200 Cells perpetually face the decision to proliferate or to stay quiescent.

201 Their effect on personal decisions to purchase firearms is not well-understood.

202 mpleted an fMRI choice task, making repeated decisions to purchase or decline 1-12 placebo or active

203 The decision to pursue an invasive strategy is complicated b

204 The decision to pursue CT screening for lung cancer is a tim

205 on of diffuse infiltrative glioma guides the decision to pursue definitive neurosurgical resection.

206 The decision to pursue EVS should be individualized for each

207 The decision to pursue GS is strongly influenced by a GS men

208 The decision to pursue GS or SS was made during residency by

209 The decision to pursue rhythm control is based on symptoms,

210 Demanding tasks often require a series of decisions to reach a goal.

211 f the outcomes associated with their initial decision to recall.

212 The decision to receive treatment for AK varied from 57.7% (

213 Thus, the decision to recommend PMRT requires a great deal of clin

214 also a need for research to support land use decisions to reconcile economic development, great ape c

215 reaks in Russia and Sweden in 2016, critical decisions to reduce morbidity and mortality include rapi

216 of negative images could be used to predict decisions to regulate affective responses to those image

217 These brain variables predicted future decisions to regulate emotion beyond what could be predi

218 Our results revealed the following: (1) decisions to regulate were more frequent in individuals

219 lesser valued option, females execute their decision to reject this inferior substrate not by stoppi

220 essing, adds to carer burden, and influences decisions to relocate people to care homes.

221 Stem cell fate decisions to remain quiescent, self-renew or differentia

222 important roles in regulating physiological decisions to reproduce, grow, and age.

223 ecision to take daily tenofovir as PrEP, the decision to return for at least one PrEP follow-up visit

224 The decision to revise a graft was based on the judgment of

225 The decision to screen for colorectal cancer in adults aged

226 ACP recommends that clinicians base the decision to screen for prostate cancer using the prostat

227 ts how a focus on patient-side delays in the decision to seek care can conceal the fact that many hea

228 ouraging CPM on patient care satisfaction or decisions to seek treatment from another clinician.

229 Seven experiments explore people's decisions to share or withhold personal information, and

230 An understanding of how the decision to sleep is affected by these other drives and

231 ributed reliably to this neural signature of decisions to smoke cannabis.

232 to investigate neural activation underlying decisions to smoke cannabis.

233 ld be continued perioperatively, whereas the decision to start a beta-blocker should be individualize

234 The decision to start ART was determined by CD4 count for on

235 ists are frequently faced with the important decision to start or terminate a creative partnership.

236 The decision to start screening mammography in women prior t

237 sting for STIs should also inform individual decisions to start pre-exposure prophylaxis.

238 ribute to the Drosophila larval sensorimotor decision to startle, explore, or perform a sequence of t

239 at C. elegans are able to judiciously make a decision to stay on stiffer regions.

240 The decision to stop anticoagulants at 3 months or to treat

241 The decision to stop anticoagulants at 3 months or to treat

242 n menopause-specific QOL influence a woman's decision to stop chemoprevention therapy.

243 the most relevant factor to consider in the decision to stop CTX after ART-induced immune reconstitu

244 s that NSBBs did not increase mortality; the decision to stop NSBB treatment in relation to stressful

245 ial NSBB users stopped taking NSBBs, and the decision to stop NSBB treatment marked a sharp rise in m

246 hese two states have specific effects on the decisions to stop at and leave proteinaceous food patche

247 Decisions to stop or continue donepezil treatment should

248 uring World War I explain how he came to the decision to stray and to stay so far from his roots.

249 coherence suppression protocol, in which the decision to suppress decoherence on an entangled two-qub

250 nce of stress, the mechanisms underlying its decision to sustain copulation are unclear.

251 probability of migrating, and, secondly, the decision to switch between migratory strategies.

252 We also found that the decision to switch from replication to differentiation i

253 ionale and evidence that supports the policy decision to switch from trivalent OPV to bivalent OPV an

254 n-making, usually applied to cell-autonomous decisions, to systems that collectively make decisions t

255 ssion to examine factors associated with the decision to take daily tenofovir as PrEP, the decision t

256 ular screening examination can influence the decision to take part in the other type of cardiovascula

257 EP, suggesting that participants based their decision to take PrEP, at least in part, on their percei

258 Using platelet count trends to guide decision to test for heparin-induced thrombocytopenia is

259 rm a decision variable, linking the evolving decision to the formation of a motor plan.

260 ation targeted at another, they change their decision to the most punitive option.

261 vmPFC/mOFC) is involved in constraining the decision to the relevant options.

262 The apes successfully adapted their decisions to the social context and their performance wa

263 ated earlier, consistent with binding action decisions to their ensuing outcome.

264 ies the target interval and may instruct the decision to time the action on a trial-by-trial basis.

265 measure of kidney quality which may aid the decision to transplant the kidney.

266 The decision to treat a patient in primary prevention must b

267 The decision to treat should be based on careful considerati

268 ECOG performance status 0 to 2 and clinical decision to treat with bisphosphonates within 3 months o

269 ions, and may take multiple medications, the decision to treat with statins must be individualized.

270 In Drosophila, the decision to trigger apoptosis--whether in response to de

271 anisms, priors also clearly oriented initial decisions to trust, reflected in medial prefrontal corte

272 olfactory and visual signals upstream of the decision to turn.

273 The decision to undergo mitral valve surgery is often made o

274 ng important clinical decisions, such as the decision to undergo MR surgery.

275 tatus of Miro phosphorylation influences the decision to undergo Parkin-dependent mitochondrial arres

276 patients indicated they had made the correct decision to undergo surgery.

277 ase, co-ordinate regulation may optimize the decision to undertake a final cell division as nutrients

278 Decisions to upgrade were influenced by predictors of be

279 The decision to use a cheap oral killed whole-cell cholera v

280 ecause every model performed acceptably, the decision to use a given model should depend on practical

281 mogenic media tested and may factor into the decision to use a particular medium.

282 sed risk for CDI should be factored into the decision to use acid suppression medication in children.

283 In the absence of severe poisoning, the decision to use extracorporeal treatment is determined b

284 Ultimately, the decision to use mesh should be based upon a patient's pe

285 5 hours with high accuracy and may guide the decision to use thrombolysis in patients with unknown ti

286 a pathology of choice, defined by continued decisions to use drugs irrespective of negative conseque

287 inically relevant decisions drug users make: decisions to use drugs.

288 Decisions to use statins in older individuals are made i

289 s one of the most important factors in their decision to vaccinate their children.

290 amples can vary from trial to trial, causing decisions to vary.

291 The decision to withdraw a drug should be made for each indi

292 Death often follows a decision to withdraw life-sustaining treatments.

293 e often inaccurate and may lead to premature decisions to withdraw life-sustaining treatments (LST) i

294 cardiopulmonary arrest survivors die after a decision to withdrawal of life-sustaining treatment and

295 In the acute setting, the decision to withhold anticoagulants is based on an indiv

296 halopathy after cardiac arrest occur after a decision to withhold or withdraw life-sustaining treatme

297 ed the effect of opioid ADE understanding on decisions to withhold opioids when ADEs (i.e., nausea/vo

298 ve evaluated the influence of preferences on decisions to withhold prescribed opioids for children.

299 explored how parents' preferences influenced decisions to withhold prescribed opioids when faced with

300 The decision to work sick is shaped by systems-level and soc